Isolated Pancreas Transplantation for Type 1 Diabetes: A Doctor's Dilemma

JAMA

Volumn 290, Issue 21, 2003, Pages 2861-2863

  Nathan, David M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

DIALYSIS; DRUG FORMULATION; GLUCOSE BLOOD LEVEL; GRAFT REJECTION; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MORTALITY; NOTE; PANCREAS TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; RISK BENEFIT ANALYSIS;

EID: 0345530009     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.290.21.2861     Document Type: Note

References (22)

1. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med. 1993; 328:1676-1685.
2. Russell JD, Beecroft ML, Ludwin D, Churchill DN. The quality of life in renal transplantation-a prospective study. Transplantation. 1992;54:656-660.
3. Wolf RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341:1725-1730.
4. Kelly WD, Lillehei RC, Merkel FK, Idezuki Y, Goetz FC. Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery. 1967;61:827-837.
5. Cosimi AB, Auchincloss H, Delmonico FL, et al. Combined pancreatic and renal transplantation in diabetics. Arch Surg. 1988;123:621-625.
6. Robertson RP, David C, Larsen J, Stratta R, Sutherland DER. Pancreas and islet transplantation for patients with diabetes. Diabetes Care. 2000;23:112-116.
7. Kinkhabwala M, Wilkinson A, Danovitch G, et al. The role of whole organ pancreas transplantation in the treatment of type 1 diabetes. Am J Surg. 1996;171: 516-520.
8. Nathan DM, Fogel HA, Norman D, et al. Long-term metabolic and quality of life results with pancreatic/renal transplantation in IDDM. Transplantation. 1991; 52:85-91.
9. Gross CR, Limwattananon C, Matthees B, Zehrer JL, Savik K. Impact of transplantation on quality of life in patients with diabetes and renal dysfunction. Transplantation. 2000;70:1736-1746.
10. Kennedy WR, Navarro X, Goetz FC, Sutherland DER, Najarian JS. Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med. 1990;322:1031-1037.
11. Fioretto P, Steffes MW, Sutherland DER, Goetz FC, Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med. 1998; 339:69-75.
12. Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
13. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000;342:381-389.
14. Writing Team for the Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications Research Group. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. JAMA. 2003;290:2159-2167.
15. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial (published correction appears in Arch Ophthalmol. 1998;116:1469]. Arch Ophthalmol. 1998;116:874-886.
16. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial (published correction appears in Arch Ophthalmol. 1998;116:1469]. Arch Ophthalmol. 1998;116:874-886.
17. Diabetes Control and Complications Trial Research Group. Lifetime benefits of intensive therapy as practiced in the Diabetes Control and Complications Trial. JAMA. 1996;276:1409-1415.
18. Venstrom JM, McBride MA, Rother KI, Hirshberg B, Orchard TJ, Harlan DM. Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA. 2003;290:2817-2823.
19. Robertson RP, Holohan TV, Genuth S. Therapeutic controversy: pancreas transplantation for type 1 diabetes. J Clin Endocrinol Metab. 1998;83:1868-1874.
20. Robertson RP, Davis C, Larsen J, Stratta R, Sutherland DE, American Diabetes Association. Pancreas transplantation for patients with type 1 diabetes. Diabetes Care. 2003;26(suppl 1):S120.
21. University of Michigan Pancreas Transplant Evaluation Committee. Pancreatic transplantation as treatment for IDDM: proposed candidate criteria before end-stage diabetic nephropathy. Diabetes Care. 1988;11:669-675.
22. Shaw GB. The Doctor's Dilemma. Baltimore, Md: Penguin Books; 1954.